" class="no-js "lang="en-US"> Steven Blakely - Medtech Alert
Tuesday, August 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Steven Blakely

Steven Blakely

About Steven Blakely

Related Story

Diseases

 Bio-Rad Introduces CFX Opus Deepwell Real-Time PCR Detection System | Pharmtech Focus

Bio-Rad Introduces CFX Opus Deepwell Real-Time PCR Detection System

June 28 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]

Equipment

 Bio-Rad Launches CFX Duet Real-Time PCR System | Pharmtech Focus

Bio-Rad Launches CFX Duet Real-Time PCR System

May 27 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Equipment

 Bio-Rad Launches its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics | Pharmtech Focus

Bio-Rad Launches its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics

October 22 2021

Bio–Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic […]